Alphatec Holdings Inc
$ 9.31
1.09%
07 Aug - close price
- Market Cap 1,437,940,000 USD
- Current Price $ 9.31
- High / Low $ 9.34 / 9.04
- Stock P/E N/A
- Book Value -0.04
- EPS -0.71
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.03 %
- ROE -3.73 %
- 52 Week High 23.29
- 52 Week Low 6.82
About
Alphatec Holdings, Inc., a medical technology company, designs, develops and advances technologies for the surgical treatment of spinal disorders. The company is headquartered in Carlsbad, California.
Analyst Target Price
$15.86
Quarterly Earnings
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2026-08-04 | 2026-05-05 | 2026-02-24 | 2025-10-30 | 2025-07-31 | 2025-05-01 | 2025-02-26 | 2024-10-30 | 2024-07-31 | 2024-05-07 | 2024-02-27 | 2023-11-06 |
| Reported EPS | -0.16 | -0.2201 | 0.06 | 0.03 | 0.02 | -0.09 | -0.0638 | -0.13 | -0.14 | -0.16 | -0.37 | -0.11 |
| Estimated EPS | -0.12 | -0.0036 | 0.0375 | -0.02 | -0.04 | -0.12 | -0.0375 | -0.11 | -0.12 | -0.14 | -0.25 | -0.08 |
| Surprise | -0.04 | -0.2165 | 0.0225 | 0.05 | 0.06 | 0.03 | -0.0263 | -0.02 | -0.02 | -0.02 | -0.12 | -0.03 |
| Surprise Percentage | -33.3333% | -6013.8889% | 60% | 250% | 150% | 25% | -70.1333% | -18.1818% | -16.6667% | -14.2857% | -48% | -37.5% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: ATEC
2026-08-08 04:11:05
Tyson Eliot Marshall, General Counsel of Alphatec Holdings (NASDAQ:ATEC), sold 8,168 shares for a total of $78,821 to cover tax withholding obligations from vested restricted stock units. This sale was conducted under a Rule 10b5-1 trading plan. Despite the stock being down 56% year-to-date, analysts predict a return to profitability for Alphatec Holdings this year, and the company recently reported increased Q2 revenue and adjusted EBITDA.
2026-08-08 01:11:05
Alphatec (NASDAQ:ATEC) General Counsel Tyson Eliot Marshall sold 8,168 shares of the company's stock, valued at $78,821.20, on August 5th. This transaction was part of a pre-arranged Rule 10b5-1 plan to cover tax withholding obligations from vested equity awards. Despite this insider sale, Alphatec holds a "Moderate Buy" consensus rating from analysts with an average price target of $17.40, significantly higher than its current trading price of $9.31.
2026-08-07 11:11:05
Alphatec Holdings (ATEC) has reported its Q2 and H1 2026 results, showing reduced net losses and reaffirming its full-year 2026 revenue guidance of approximately US$882 million. This positive outlook, driven by increasing surgeon adoption and procedural volumes, supports the company's investment narrative toward profitability despite ongoing losses and competitive pressures. Investors should consider how these improvements impact previous analyst expectations and the company's valuation.
2026-08-07 11:11:05
This article lists various ETFs that invest in Alphatec Holdings, Inc. (ATEC) stocks, providing details such as market value, weight, issuer, management style, focus, expense ratio, AUM, price, and performance metrics for each fund. The funds primarily target small-cap and healthcare sectors, indicating ATEC's presence within these investment strategies. The data helps potential investors identify ETFs that hold ATEC stocks, offering diversified investment opportunities.
2026-08-07 04:28:00
Alphatec Holdings (ATEC) reported narrower net losses in Q2 2026 and reaffirmed its full-year 2026 revenue guidance of approximately US$882 million. This consistent outlook, along with reduced losses, reinforces management's confidence in growth and surgical volume, but the company still faces risks related to ongoing high investment and competitive intensity affecting profitability. The article suggests these updates might shift the investment narrative and risk profile for ATEC, with some analysts potentially revising their more conservative forecasts.
2026-08-06 11:11:05
Alphatec Holdings' stock (ATEC) dropped 7.5% despite reporting improved Q2 2026 results, including narrowed losses, increased revenue, and higher adjusted EBITDA with a 17% margin. While the company showed strong surgeon adoption and operating leverage, investors remain concerned about execution risks with new products and ongoing legal investigations, which are preventing them from seeing the improved financials as a permanent fix.
